Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial
Primary Objective
This study plans to learn more about cannabidiol (CBD) as a potential treatment in patients that have Traumatic Brain Injury (TBI)-related symptoms. CBD is a chemical found in the cannabis (or hemp) plant that can be used as a medication.
Description
Our study is seeking individuals aged 18-60, who have been diagnosed with a traumatic brain injury (TBI). The goal of the study is to see whether cannabinoids (CBD) can improve TBI symptoms.
Main Procedures Involved: Main study tasks include blood draws, urine pregnancy and drug screening, questionnaires, and cognitive tests.
Duration of Participation: Your participation in this study will be 12 weeks, with 12 weeks of study medication use.
Details
Locations
Department Specific Free Standing Clinic
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Kent Hutchison, PhD
Study ID
Protocol Number: 22-1427
More information available at ClinicalTrials.gov: NCT05632627
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers